摘要
口干症,或慢性口干,是由唾液缺乏所引起的一种常见综合症,它可以导致严重的进食困难,龋齿和口腔念珠菌感染。口干症的患病率随着年龄的增加而增长,该病主要影响大约30%年龄在65岁或以上的老年人。由于大量患者存在以及人口老龄化所引起的潜在发病率的增加,对唾液分泌减少以及其对牙齿和口腔黏膜的影响的复杂机制研究显得十分重要。本文以Fgf10 +/- 鼠模型研究口干症。胚胎涎腺发育体内和体外实验表明,Fgf10减少导致了唾液腺分支的延迟。这导致腺体发育不全,这是存在于雄性或雌性Fgf10 + / -鼠中出生或成年后无法获救的特定表型。腺体的组织学分析表明,尽管细胞分化或腺泡和导管的安排并没有明显的缺陷,但是他们的尺寸和重量显著减少。分析表明唾液分泌腺的发育不全导致成年Fgf10 + / -鼠唾液分泌显著减少,并使这些Fgf10 + / -鼠口腔唾液黏膜变薄。结果表明成年老鼠饮水更多,并且在许多情况下都有严重的牙齿磨损。因此,Fgf10 +/-鼠是一种用来探索口干症原因和影响的有用模型。
关键词: 分支形态,Fgf10,唾液,唾液腺功能障碍,牙齿磨损,口干症
Current Molecular Medicine
Title:Salivary Gland Dysplasia in Fgf10 Heterozygous Mice: A New Mouse Model of Xerostomia
Volume: 15 Issue: 7
Author(s): A.J. May, L. Chatzeli, G.B. Proctor and A.S. Tucker
Affiliation:
关键词: 分支形态,Fgf10,唾液,唾液腺功能障碍,牙齿磨损,口干症
摘要: Xerostomia, or chronic dry mouth, is a common syndrome caused by a lack of saliva that can lead to severe eating difficulties, dental caries and oral candida infections. The prevalence of xerostomia increases with age and affects approximately 30% of people aged 65 or older. Given the large numbers of sufferers, and the potential increase in incidence given our aging population, it is important to understand the complex mechanisms that drive hyposalivation and the consequences for the dentition and oral mucosa. From this study we propose the Fgf10 +/- mouse as a model to investigate xerostomia. By following embryonic salivary gland development, in vivo and in vitro, we show that a reduction in Fgf10 causes a delay in branching of salivary glands. This leads to hypoplasia of the glands, a phenotype that is not rescued postnatally or by adulthood in both male and female Fgf10 +/- mice. Histological analysis of the glands showed no obvious defect in cellular differentiation or acini/ductal arrangements, however there was a significant reduction in their size and weight. Analysis of saliva secretion showed that hypoplasia of the glands led to a significant reduction in saliva production in Fgf10 +/- adults, giving rise to a reduced saliva pellicle in the oral cavity of these mice. Mature mice were shown to drink more and in many cases had severe tooth wear. The Fgf10 +/- mouse is therefore a useful model to explore the causes and effects of xerostomia.
Export Options
About this article
Cite this article as:
A.J. May, L. Chatzeli, G.B. Proctor and A.S. Tucker , Salivary Gland Dysplasia in Fgf10 Heterozygous Mice: A New Mouse Model of Xerostomia, Current Molecular Medicine 2015; 15 (7) . https://dx.doi.org/10.2174/1566524015666150831141307
DOI https://dx.doi.org/10.2174/1566524015666150831141307 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Physicochemical Properties that Determine Cellular Transport of Nanocarriers In Vitro and In Vivo
Current Organic Chemistry The Potential for Genetically Altered Microglia to Influence Glioma Treatment
CNS & Neurological Disorders - Drug Targets Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery
Current Medicinal Chemistry COX-2 Selective Inhibitors, Carbonic Anhydrase Inhibition and Anticancer Properties of Sulfonamides Belonging to This Class of Pharmacological Agents
Mini-Reviews in Medicinal Chemistry Targeting Metallothionein for Prognosis and Treatment of Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3
Current Cancer Drug Targets Telomeres and Thyroid Cancer
Current Genomics Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
Current Medicinal Chemistry Role of Inflammation in the Development of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Towards Multifunctional Synthetic Vectors
Current Gene Therapy Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression
Recent Patents on Anti-Cancer Drug Discovery Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer
Current Medicinal Chemistry Synergistic Interactions between GW8510 and Gemcitabine in an In Vitro Model of Pancreatic Cancer
Anti-Cancer Agents in Medicinal Chemistry Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Current Clinical Pharmacology The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
Current Medicinal Chemistry Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy
Current Cancer Drug Targets